{"title": "PDF", "author": "PDF", "url": "https://sesmi.es/wp-content/uploads/2017/04/Programa.pdf", "hostname": "PDF", "description": "PDF", "sitename": "PDF", "date": "PDF", "cleaned_text": "1 Metabolic Correction Institute \u00a9 2016, 2017 Terapia Integrativa de Correci\u00f3n Metabolica: Cambiando el Integrative Metabolic Metabolic Correction Institute \u00a9 2016, 2017 SALUDOS Estimados m\u00e9dicos, educadores e investigadores cl\u00ednicos: Las gu\u00edas m\u00e9dicas dan al cl\u00ednico herramientas terap\u00e9uticas que han sido evidenciadas, pero muchas veces los resultados obtenidos con estas estrategias est\u00e1n por debajo de las expectativas deseadas. A veces, las gu\u00edas m\u00e9dicas alcanzan alivio sintom\u00e1tico o el control de los factores de riesgo, pero no necesariamente la mejor\u00eda significativa o cura del paciente. Sin embargo, un an\u00e1lisis exhaustivo puede revelar importantes factores etiol\u00f3gicos en determinados individuos que al utilizarse adecuadamente puede corregir problemas anteriormente no detectados y produciendo as\u00ed mejores resultados terap \u00e9uticos. El concepto de correcci\u00f3n metab\u00f3lica fue introducido como una manera de proponer un enfoque terap\u00e9utico seguro para llegar m\u00e1s all\u00e1 del remedio sintom\u00e1tico para reconocer y manejar las anomal\u00edas bioqu\u00edmicas causantes de enfermedades espec\u00edficas. Las reacciones bioqu\u00edmicas en nuestro cuerpo dependen usualmente de la disponibilidad de los precursores y enzimas metab\u00f3licas. Para alcanzar un estado fisiol\u00f3gico sano, el organismo requiere que las reacciones bioqu\u00edmicas se producen a una velocidad contr olada que produce el equilibrio saludable. Una compleja interacci\u00f3n de m\u00faltiples variables puede alterar este equilibrio. La Terapia de Correcci\u00f3n Metab\u00f3lica Integrada (TCMI) integra los principios de correcci\u00f3n metab\u00f3lica, con otros principios m\u00e9dicos bas ados en la ciencia que identifican y atienden las causas fundamentales del disturbio en la salud. La TCMI atiende la interacci\u00f3n entre la composici\u00f3n gen\u00e9tica, los patrones alimentarios, traumatismos, enfermedades, toxinas, medicamentos y factores de estr \u00e9s ambiental. Esta interacci\u00f3n produce los cambios tales como cambios en la microbiota, alteraciones en hormonas y neurotransmisores, inflamaci\u00f3n excesiva, problemas autoinmunes, infecciones, acumulaci\u00f3n de t\u00f3xicos y demandas aumentadas de micronutrientes. TCMI incluye nutrici\u00f3n, suplementaci\u00f3n nutricional farmacol\u00f3gica, ortomoleculares, terapia de reemplazos l\u00edpidos intravenosos y el uso apropiado de medicamentos. En este curso se reunir\u00e1 el marco te\u00f3rico, el enfoque pr\u00e1ctico y la evidencia para hacer frente a varios aspectos importantes en el paciente con c\u00e1ncer, trastornos metab\u00f3licos endocrinos y trastornos neurometab\u00f3licos selectos. Incluiremos una secci\u00f3n sobre desgaste de nutrientes y disfunci \u00f3n mitocondrial inducidos por medicamentos. Como parte del curso, adem\u00e1s de las pruebas cl\u00ednicas habituales, se discuten los contaminantes org\u00e1nicos persistentes, metales pesados, los desequilibrios nutricionales espec\u00edficos, desregulaciones inmunes, marc adores de infecciones cr\u00f3nicas, las pruebas gen\u00f3micas y otros. Los resultados de estas pruebas permiten identificar las causas fundamentales para desarrollar estrategias terap\u00e9uticas que mejoren los resultados cl\u00ednicos. Al repetir las pruebas se documenta la efectividad de la terapia. Los cl\u00ednicos que usen los protocolos de este curso pueden colaborar en investigaciones y publicaciones de MCI. Jorge R. Miranda -Massari, Catedr\u00e1tico Director, Metabolic Correction Therapy Course El Instituto Correcci\u00f3n Met ab\u00f3lica (MCI) es una organizaci\u00f3n sin fines de lucro dirigida a desarrollar y llevar a cabo investigaci\u00f3n, educaci\u00f3n y servicios relacionados con las condiciones devastadoras, centr\u00e1ndose en sus causas subyacentes. Esta iniciativa est\u00e1 dirigida al bienesta r humano mediante la maximizaci\u00f3n del uso de estrategias eficaces y no t\u00f3xicas. that m any times the outcomes below guidelines of and metabolic equilibrium. Complex interactions focus on identifying and the toge ther the theoretical framework, the practical and part course in of The clinicians that use the protocols from this course cam collaborate in research and publications with MCI. initiative is aimed to maximizing human wellbeing use Desordenes Endocrinos y Neurometab\u00f3licas University of Puerto Rico Certified Program May 12 -13, 2017 Meli\u00e1 Valencia Hotel Valencia, Spain COURSE DIRECTOR Professor, Jorge R. Miranda -Massar i, PharmD University of Puerto Rico COURSE FACULITY Antonio Marco Chover, MD , Fernando Pinto, Miranda -Massari, PharmD Catedr\u00e1tico en la Escuela de Farmacia, Universidad de Puerto Rico. Posdoctorado en Farmacocin\u00e9tica Cl\u00ednica de la Universidad de Carolina del Norte. Autor de sobre 100 publicaciones en revistas arbitradas por pares y dos libros. New Insights on Vitamin C and C\u00e1ncer de la Casa Publicadora Springer Publishing (2014) y sobre el manejo Integrado de C\u00e1ncer por la casa Basic Health (2009). Es uno de los pioneros en el desarrol lo del concepto de la terapia de correcci\u00f3n metab\u00f3lica, Miembro electo a la Academia de las Artes y las Ciencias de Puerto Rico y la Academia Ibero -Americana Cient\u00edfica y Cultural en 2014 y exaltado al Sal\u00f3n de la Fama Ortomolecular en el 2016. Professor at the University of Puerto Rico, School of Pharmacy for over 25 years . Post- doctorate in Clinical P harmacokinetics at University of North Carolina. Dr. Miranda h as authored over 100 scientific publications in peer -refereed journals and two books; T he New Insights on Vitami n C and Cancer by Springer Publishing in 2014 and Integrative Cancer Management by Basic Health in 2009 . One of the pioneers of developing a concept of Metabolic Correction Therapy Approach. Inducted to the Academy of Arts and Sciences o f Puerto Rico in 2014 , the Ibero -American Scientific and Cultural Academy, and the Hall of Fame from the International Orthomolecular Medicine in 2016. The President of Metabolic Correction Institute. _____________________________________________________ _________________________________________________ Kenneth Sotller, MD Educado como pediatra en UCLA y miembro de la academia Americana de Pediatr\u00eda por dos d\u00e9cadas. Director m\u00e9dico del grupo de Medicina Integrativa y Neurolog\u00eda de Azzolino en San Francis co, California. Director M\u00e9dico de Terapia de Oxigeno Hiperb\u00e1rico de San Francisco. Miembro Vitalicio del Colegio Americano de Medicina Hiperb\u00e1rica. Principal Oficial Medico de Veritas Medical Diagnostics . Dr. Stoller is an Assistant Professor at the AT Still School of Medicine Arizona. He was trained as a pediatrician at UCLA and was a fellow of the American Academy of Pediatrics for two for two decades. Medical Director at the Azzolino Integrative Medicine & Neurology Group in San Francisco, CA. Medica l Director of Hyperbaric Oxygen Therapy of San Francisco. Dr. Stoller has been working with patients with brain injuries ranging from -brain, Lyme brain since the late MCI Research Protocols from the University Valencia. Diplomate in higher studies in Sophrologic Medicine. of Doctors for plurality in medicine). Professor at master program of natural medicine, acupuncture, homeopathy and orthomolecular medicine. Specialist in oxidation hemotherapy. Licenciado en medicina y cirug\u00eda por la Universidad de Valencia. Diplomado en estudios superiores en Medicina sofrol\u00f3gica. Vicepresidente espa\u00f1ol del ECPM (European Council of Doctors for plurality in medici ne). Profesor de diversos masters sobre medicina naturista, acupuntura, homeopat\u00eda y orthomolecular . Miembro de la Sociedad alemana HOT (terapia por oxidaci\u00f3n hematogone ) ___________________________________________________________________________________ _______________________________________________ Jesus Caquias, MD Medicina General, Medicina ACAM, A4M, Certificado en Terapia de reemplazo de l\u00edpidos, Creador de protocolos de MCI y sobre 20,000 tratamientos intravenosos. (Comando fluido de ingl\u00e9s y espa\u00f1ol) General Family Medicine, Medicine, Dr. Jesus Caquias is a family medicine doctor in Brownsville, Texas. He received his medical d egree from Meharry Medical College in New York and has b een in practice for more than 25 years. Contributor of MCI Protocols , Research 20,00 Intravenous therapies . 7 Metabolic 9:45 a.m. Welcome: Dr. A. Marco Chover and Professor, Jorge Miranda -Massari Pre-Exam 9:45 a.m. - a.m. Lipid Signaling Pathways 11:30 a.m. - 11:45 a.m. Q&A / Coffee Brake 11:45 a.m. - 12:45 a.m. Genetics 12:45 a.m. - 1:45 p.m. Integrative Cancer Assessment and Treatment Options I 7. History and Physical Exam 8. Laboratory testing 9. Treatments a. Diet b. 2017 p.m. Lunch 3:45 p.m. - 5:00 p.m. Integrative Cancer Reducing the load of t oxic metals that damage the mitochondria and the gene expression. e. Chelation IV Therapies i. DMPS ii. EDTA f. p.m. 5:15 p.m. - 6:30 Integrative Ozone IM Blood I (UVBI) 15. Exercise, Home, Work and Spirituality 6:30 p.m. - 7:30 p.m. 4 Case Studies / Q&A / Discussions Post-Exam 9 Metabolic a.m. Registrations 9:30 - a.m . Welcome: Dr. Chover and Professor, Jorge Miranda -Massari Pre-Exam 9:45 a.m. - 10:00 a.m. Background of Autism Spectrum Disorder (ASD) 16. Definition of ASD 17. Demography US and Spain 18. Mortality morbidity 19. QoL 20. Costs 10:00 a.m. - 11:30 Genetic Factors in ASD 21. Inborn Errors of m. Drug Metabolism i. Acetaminophen n. Hormones 11:30 a.m. - 11:45 a.m. Q&A / Coffee Brake 11:45 a.m. - 12:45 a.m. Assessments and Treatments of ASD 23. Medical o. History Form p. Physical Exam q. s. Aggressive Behaviors Correction Therapy: 27. S yndrome 30. GALT and Immune system 1:45 p.m. - 3:45 p.m. Lunch 3:45 p.m. 5:00 Chronic Fatigue and atigue 35. Multiple Micronutrients 39. Disease DIA 1 (DAY 1) CANCER 1. Identificando y Reduciendo Riesgos para el desarrollo C\u00e1ncer Identifying & Reducing Cancer Risks 1.1. Trasfondo (Definiendo c\u00e1ncer y sus terapias ) Background (Defining cancer and its treatments) 1.2. Epidemiolog\u00eda de system Diet, Contaminantes org\u00e1nicos Organic pollutants 1.4. Epigen\u00e9tica y v\u00edas Metab\u00f3licas Secundarias en la Regulaci\u00f3n de D iferenciaci\u00f3n del C\u00e1ncer Epigenetics and Metabolic Pathways and Molecular Regulation in Cancer 1.5. Da\u00f1o y reparaci\u00f3n del DNA (DNA ) Micronutrientes/contaminantes/i Exercise 1.5.4. Ambiente del hogar Home environment 1.5.5. Ambiente de trabajo Work environment 1.5.6. Espiritualidad Spirituality 1.5.7. Otros factores Others Factors 2. Historial comprensivo y examen f\u00edsico completo PROGR AM 12 Metabolic Correction Institute \u00a9 2016, 2017 en el manejo de pacientes con c\u00e1ncer Comprehensive history and complete physical exam for management in cancer patients 3. Pruebas de laboratorio y aplicaciones cl\u00ednicas en el paciente con c\u00e1ncer Advanced clinical laboratory testing and clinical applications for patients with Panel de enfermedades infecciosas Infectious disease panel 3.1.7. Panel de metales pesados Heavy metals panel 3.1.8. Contaminantes org\u00e1nicos Organic contaminants 4. Manejo Avanzado de Vitamina C en C\u00e1ncer y otras terapias intraveno sas Advanced Vitamin C and other IV treatments in Cancer 5. Manejo Metab\u00f3lico Comprensivo en el manejo del paciente con c\u00e1ncer Comprehensive Metabolic therapies in Cancer Management 5.1. Dieta Diet 5.2. Oral Supplements Suplementos Orales 5.3. Oral Medications Medicamentos orales 6. Manejo del dolor Pain management 6.1. Consideraciones nutricionales Dietary considerations 6.2. Suplementos Supplements 6.3. Medicamentos Medications 7. IVC enfermedades infecciosas IVC therapies Referencias References 11. Cancer Research Collaboration with MCI DIA 2 (DAY 2) AUTISMO Y OTROS DESORDENES NEUROMETABOLICOS AUTISM AND OTHER NEUROMETABOLIC DISORDERS 12. Terapia Integrada de C orrecci\u00f3n d Autismo Integrative Metabolic Correction del Metabolismo Inborn Error of Metabolism (IEM) 12.4.2. Amino \u00c1cidos Lifestyle Hogar M\u00e9dico Medical Home 12.5.6. Padres y hermanos Parents and Siblings 13. Correcci\u00f3n Metab\u00f3lica Alzheimer's Disease 13.5. Esquizofrenia Schizophrenia 14. Correcci\u00f3n Metab\u00f3lica Key micronutrients) 16.1.5. Estudio de Fatiga Cr\u00f3 nica y Adrenal Chronic and Adrenal 16 Disease nutrition. now recognized exposures, . The panel advised the President \"to use the power of his office to remove the carcinogens and other toxins from our food, water, and air that increase s health care costs, decreases our productivit y, and devastate American lives. \" Understanding about the role of toxic chemicals, nutritional imbalances, on the development more can influence metaboli sm, alter brain growth and play a substantial the 3 1.2. Mitochondrial Dysfunction Cancer has been differentiation and/or or of Epigenetics is the study of changes in gene expression that does not involve changes to the underlying DNA sequence but that influences 1. Epigenetic change can be influenced by factors such age, the insights the treatment of many diseases. New technology will enable the analysis of large groups of complex molecular and clinical data for understanding how inflammation and metabolism the three basic needs of dividing cells: rapid ATP generation macromolecules; appropriat cell s modifications carbohydrates, and cells, these adaptations must be implemented in the stressful and dynamic microenvironment of th e solid tumor, where of rks are dynamic, change with age, and are influenced by the external environment. Thus, epigenetics provides a link between the environment, diet, and cancer development. Proper food selection is imperative for better health and to cancer in different tumor A number of natural foods and their bioactive components have from aerobic respiration toward glycolysis, 10Such alterations in cellular metabolism may favor tumor increasing the availability of biosynthetic intermediates cancer. Mitochondrial ROS may contribute to cancer via DNA damage he activation aberrant Damage and Repair in Cancer. The relevance of DNA damage and repair to carcinogenesis became evident when it was recognized that all agents that cause cancer (carcinogens) also cause a change in the DNA sequence and thus are mutagens.12 All the effects of carcinogenic chemicals on tumor production can be accounted for by the DNA damage that they cause and by the errors i ntroduced into DNA during the modify also cause cancer in animals and can normal cells in culture activity, and smoking) have been linked to a higher risk of much medical comorbidity (cardiovascular, metabolic, etc.). There is increasing evidence linking these factors to factor for multiple cancers. Various molecular mechanisms have been put forth to explain the association between body weight and cancer meet the current dietary guidelines. Glycemic load has been documented to impa ct and overall has not been advocated in in 1.6 Testing Laboratory tests in patients suspected to have cancer may include bi opsy of a suspicious area, to in the arrival of the correct diagnosis. The samples may show cancer cells, proteins or other substances made by the cancer cells. Blood tests can also reflect the functionality of certain organ systems and metastasis. for and monitoring define the Tumor Markers Genomic Testing IL-, 1, 6, 17, 21 23, 27, Others Inflammation panel Environmental Reuben for the President's Cancer Panel, US Department of Health and Human Services, National Institutes of Health, National Cancer Institute. Reducing Environmental Cancer Risk. What We Can 2010, http://deainfo.nci.nih.gov/advisory/pcp/annualReports/pcp08 -09rpt/PCP_Report_08 -09_508.pdf . 3 Sly PD, Carpenter DO, Berg M, et al.Health Consequences of Environmental Exposures: Causal S, Cuy\u00e0s E, Lucia no-Mateo F, Cabre N, Camps J, Lopez -Miranda J, Menendez in cancer: at crossroads of life and death. Chin J Cancer. 2011;30(8):526 - 39. 12 Lodish H, Berk A, Zipursky et al. Molecular Cell Biology. 4th edition. New Factors in Survivorship: Where We Are Headed. J Pers Med. 2015;5(3):243 -63. R, A, in cancer. Support Care Cancer. 2006 Feb;14(2):193 -9. 16 National Canc er Institute, NIH. Center causing "}